دورية أكاديمية
أعرض في EDS

Effect of ethanol exposure on innate immune response in sepsis.

التفاصيل البيبلوغرافية
العنوان: Effect of ethanol exposure on innate immune response in sepsis.
المؤلفون: Roychowdhury S; Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States., Pant B; Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States., Cross E; Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States., Scheraga R; Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States.; Department of Pulmonary and Critical Care Medicine, Integrated Hospital-Care Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195, United States., Vachharajani V; Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States.; Department of Pulmonary and Critical Care Medicine, Integrated Hospital-Care Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195, United States.
المصدر: Journal of leukocyte biology [J Leukoc Biol] 2024 May 29; Vol. 115 (6), pp. 1029-1041.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : Oxford : Oxford University Press
Original Publication: New York : Alan R. Liss, c1984-
مواضيع طبية MeSH: Immunity, Innate*/drug effects , Sepsis*/immunology , Ethanol*/adverse effects , Ethanol*/pharmacology, Humans ; Animals
مستخلص: Alcohol use disorder, reported by 1 in 8 critically ill patients, is a risk factor for death in sepsis patients. Sepsis, the leading cause of death, kills over 270,000 patients in the United States alone and remains without targeted therapy. Immune response in sepsis transitions from an early hyperinflammation to persistent inflammation and immunosuppression and multiple organ dysfunction during late sepsis. Innate immunity is the first line of defense against pathogen invasion. Ethanol exposure is known to impair innate and adaptive immune response and bacterial clearance in sepsis patients. Specifically, ethanol exposure is known to modulate every aspect of innate immune response with and without sepsis. Multiple molecular mechanisms are implicated in causing dysregulated immune response in ethanol exposure with sepsis, but targeted treatments have remained elusive. In this article, we outline the effects of ethanol exposure on various innate immune cell types in general and during sepsis.
Competing Interests: Conflict of interest statement. None declared.
(© The Author(s) 2023. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
References: Alcohol Clin Exp Res. 2011 May;35(5):787-93. (PMID: 21284667)
Basic Res Cardiol. 2017 Mar;112(2):16. (PMID: 28168403)
J Immunol. 2004 Aug 15;173(4):2715-24. (PMID: 15294990)
Infect Immun. 2013 Feb;81(2):460-9. (PMID: 23208605)
J Leukoc Biol. 2019 Jul;106(1):161-169. (PMID: 30946496)
Sci Rep. 2016 Nov 04;6:36624. (PMID: 27812043)
J Infect Dis. 2005 Apr 15;191(8):1280-6. (PMID: 15776374)
Redox Biol. 2014 Aug 01;2:929-35. (PMID: 25180169)
Front Immunol. 2017 Dec 11;8:1781. (PMID: 29321780)
Front Immunol. 2022 Aug 29;13:934617. (PMID: 36105802)
Crit Care Med. 2007 Feb;35(2):345-50. (PMID: 17205003)
Inflammation. 2019 Aug;42(4):1301-1310. (PMID: 30887396)
Mediators Inflamm. 2016;2016:3758590. (PMID: 28090151)
Nat Immunol. 2011 Jan;12(1):21-7. (PMID: 21113163)
J Immunol. 2004 Mar 1;172(5):2811-7. (PMID: 14978081)
J Leukoc Biol. 2015 Apr;97(4):769-78. (PMID: 25605871)
Alcohol. 2006 Jun;39(2):105-10. (PMID: 17134663)
PLoS One. 2017 Aug 3;12(8):e0182427. (PMID: 28771573)
Hepatology. 2006 May;43(5):989-1000. (PMID: 16628628)
JAMA Netw Open. 2023 Feb 1;6(2):e2255496. (PMID: 36757694)
Sci Rep. 2018 Sep 10;8(1):13536. (PMID: 30201980)
JAMA. 2016 Feb 23;315(8):801-10. (PMID: 26903338)
Clin Exp Immunol. 1999 Jul;117(1):63-9. (PMID: 10403917)
Lab Invest. 2006 Mar;86(3):254-61. (PMID: 16446706)
Intensive Care Med Exp. 2016 Dec;4(1):5. (PMID: 26879814)
J Biol Chem. 2016 Jan 1;291(1):149-59. (PMID: 26527689)
Crit Rev Oncol Hematol. 2012 Jun;82(3):296-309. (PMID: 21798756)
J Immunol. 2015 Dec 1;195(11):5169-77. (PMID: 26525287)
Mediators Inflamm. 2020 May 11;2020:3201635. (PMID: 32454788)
Platelets. 2022 Nov 17;33(8):1251-1259. (PMID: 35920588)
Shock. 2014 May;41(5):449-53. (PMID: 24430550)
J Immunol. 2001 Nov 15;167(10):5645-52. (PMID: 11698436)
Alcohol Clin Exp Res. 2002 Jan;26(1):65-73. (PMID: 11821656)
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:242-51. (PMID: 26375241)
J Immunol. 2011 Jan 1;186(1):195-202. (PMID: 21106855)
JCI Insight. 2018 Jun 7;3(11):. (PMID: 29875325)
Immunotherapy. 2011 Jun;3(6):727-9. (PMID: 21668309)
Crit Care Med. 2004 Jul;32(7):1460-9. (PMID: 15241089)
Brain Behav Immun. 2015 Aug;48:1-7. (PMID: 25816800)
Crit Care Med. 2014 Jun;42(6):1579-80. (PMID: 24836809)
Front Immunol. 2021 Feb 24;12:614429. (PMID: 33717101)
Crit Care. 2009;13(3):R72. (PMID: 19454002)
Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S490-7. (PMID: 16237652)
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):397-411. (PMID: 29748586)
Front Cell Infect Microbiol. 2021 Mar 17;11:653228. (PMID: 33816356)
PLoS One. 2014 Feb 14;9(2):e87915. (PMID: 24551070)
Shock. 2012 Feb;37(2):177-82. (PMID: 22089189)
Infect Immun. 1994 Oct;62(10):4244-9. (PMID: 7927680)
Brain Behav Immun. 2017 May;62:291-305. (PMID: 28232172)
Front Immunol. 2017 Oct 30;8:1414. (PMID: 29163491)
Immunopharmacol Immunotoxicol. 2002 Feb;24(1):121-38. (PMID: 12022440)
Mediators Inflamm. 2020 Feb 7;2020:4235909. (PMID: 32089644)
J Leukoc Biol. 1995 Sep;58(3):342-50. (PMID: 7665990)
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):166S-71S. (PMID: 16344604)
Hepatology. 2008 Oct;48(4):1224-31. (PMID: 18792393)
Crit Care Med. 2020 Mar;48(3):276-288. (PMID: 32058366)
Life Sci. 2003 Mar 7;72(16):1825-39. (PMID: 12586220)
Mol Med Rep. 2021 Jul;24(1):. (PMID: 33982766)
IUBMB Life. 2021 Jul;73(7):900-915. (PMID: 34033211)
Alcohol Clin Exp Res. 2015 Oct;39(10):2022-31. (PMID: 26334550)
Surgery. 2002 Aug;132(2):205-12. (PMID: 12219013)
Front Immunol. 2021 Jul 08;12:697588. (PMID: 34305934)
J Neuroimmune Pharmacol. 2014 Dec;9(5):668-78. (PMID: 25135400)
Cell Mol Life Sci. 2021 Feb;78(4):1233-1261. (PMID: 33057840)
Genomics. 2021 May;113(3):1219-1233. (PMID: 33691144)
Shock. 2017 Mar;47(3):313-317. (PMID: 27488091)
Front Immunol. 2019 Oct 30;10:2536. (PMID: 31736963)
Science. 2002 Apr 12;296(5566):301-5. (PMID: 11951032)
Crit Care. 2012 Oct 25;16(5):R206. (PMID: 23098236)
Alcohol. 2004 Jul;33(3):235-9. (PMID: 15596092)
Front Immunol. 2021 May 18;12:652488. (PMID: 34084163)
Front Immunol. 2020 Apr 28;11:532. (PMID: 32411122)
Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1192-1196. (PMID: 37577797)
Front Immunol. 2019 May 29;10:1222. (PMID: 31191558)
J Leukoc Biol. 2016 Dec;100(6):1239-1254. (PMID: 27671246)
Front Immunol. 2023 Jan 27;13:1079962. (PMID: 36865524)
Nat Rev Immunol. 2016 Jan;16(1):35-50. (PMID: 26711677)
J Infect Dis. 2001 Nov 1;184(9):1134-42. (PMID: 11598836)
Science. 2004 Mar 5;303(5663):1532-5. (PMID: 15001782)
Gut. 2019 Aug;68(8):1504-1515. (PMID: 30448775)
J Immunol. 2019 Dec 15;203(12):3190-3198. (PMID: 31722987)
Diagn Pathol. 2013 Feb 15;8:24. (PMID: 23414215)
Ernst Schering Found Symp Proc. 2007;(3):83-95. (PMID: 18510100)
J Immunol. 2009 Jun 15;182(12):7846-54. (PMID: 19494309)
J Innate Immun. 2014;6(3):339-52. (PMID: 24281714)
Crit Care. 2021 Feb 6;25(1):50. (PMID: 33549126)
Shock. 2023 Feb 1;59(2):239-246. (PMID: 36512674)
J Hepatol. 2023 Jan;78(1):28-44. (PMID: 36063965)
Clin Biochem. 2001 May;34(3):189-93. (PMID: 11408016)
J Endotoxin Res. 2003;9(2):101-7. (PMID: 12803883)
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4563-4569. (PMID: 34286499)
Immunology. 2018 Feb;153(2):190-202. (PMID: 29064085)
Clin Diagn Lab Immunol. 2002 May;9(3):530-43. (PMID: 11986256)
J Leukoc Biol. 2013 Jul;94(1):171-82. (PMID: 23625200)
Blood. 2003 May 15;101(10):3765-77. (PMID: 12543869)
Innate Immun. 2015 Feb;21(2):115-26. (PMID: 24406749)
J Immunol. 2017 Feb 1;198(3):1320-1333. (PMID: 28031340)
Blood. 2010 Oct 21;116(16):e74-80. (PMID: 20628149)
Gastroenterology. 2010 Aug;139(2):664-74, 674.e1. (PMID: 20416309)
Sci Rep. 2022 Jan 13;12(1):685. (PMID: 35027618)
Infect Dis Ther. 2022 Apr;11(2):771-786. (PMID: 35169996)
PLoS Pathog. 2017 Sep 18;13(9):e1006637. (PMID: 28922428)
Alcohol Clin Exp Res. 2016 Nov;40(11):2260-2270. (PMID: 27650785)
J Immunol. 2015 Sep 1;195(5):2353-64. (PMID: 26216888)
Cell Prolif. 2022 Dec;55(12):e13328. (PMID: 36106559)
J Neuroinflammation. 2019 Nov 27;16(1):239. (PMID: 31775794)
Front Immunol. 2023 Jan 13;13:1066456. (PMID: 36713399)
Trends Immunol. 2001 Nov;22(11):633-40. (PMID: 11698225)
J Biol Regul Homeost Agents. 2020 Sep-Oct;34(5):1719-1727. (PMID: 33179463)
Nat Immunol. 2012 Dec;13(12):1145-54. (PMID: 23160217)
Alcohol Clin Exp Res. 2019 Mar;43(3):411-424. (PMID: 30589437)
Alcohol Clin Exp Res. 2012 May;36(5):835-46. (PMID: 22150547)
Blood. 2016 Nov 10;128(19):2327-2337. (PMID: 27609642)
Alcohol Clin Exp Res. 2015 May;39(5):763-75. (PMID: 25872593)
Alcohol Clin Exp Res. 2009 Sep;33(9):1524-31. (PMID: 19485975)
Alcohol. 2015 Feb;49(1):57-64. (PMID: 25572859)
Toxicol Appl Pharmacol. 2015 Jan 15;282(2):139-50. (PMID: 25499027)
Hepatology. 2011 Dec;54(6):2185-97. (PMID: 21826694)
Mol Immunol. 2005 Feb;42(4):501-10. (PMID: 15607806)
Alcohol Clin Exp Res. 1997 Sep;21(6):981-7. (PMID: 9309305)
Science. 2002 Apr 12;296(5566):298-300. (PMID: 11951031)
Alcohol Clin Exp Res. 2006 Aug;30(8):1436-44. (PMID: 16899048)
Surg Infect (Larchmt). 2018 Feb/Mar;19(2):107-116. (PMID: 29364781)
Front Immunol. 2022 Jun 29;13:911951. (PMID: 35844518)
Trends Immunol. 2009 Oct;30(10):475-87. (PMID: 19781994)
Cancer Cell. 2009 Sep 8;16(3):183-94. (PMID: 19732719)
Alcohol. 2011 Dec;45(8):795-803. (PMID: 21872420)
Alcohol Clin Exp Res. 2004 May;28(5):824-8. (PMID: 15166660)
J Appl Physiol (1985). 1992 Jan;72(1):8-14. (PMID: 1537746)
Eur J Trauma Emerg Surg. 2022 Aug;48(4):2689-2699. (PMID: 33783566)
Toxicology. 2015 Aug 6;334:104-10. (PMID: 26079697)
J Leukoc Biol. 2015 May;97(5):963-973. (PMID: 25740962)
Blood. 1996 Jun 15;87(12):5144-51. (PMID: 8652827)
Mol Cell. 2002 Aug;10(2):417-26. (PMID: 12191486)
Crit Care Med. 2017 Feb;45(2):253-262. (PMID: 27632674)
Toxicol Sci. 2010 Oct;117(2):314-24. (PMID: 20624996)
Alcohol Clin Exp Res. 2011 Apr;35(4):584-94. (PMID: 21223299)
Biomark Res. 2014 Jan 07;2(1):1. (PMID: 24398220)
JAMA. 2011 Dec 21;306(23):2594-605. (PMID: 22187279)
Cytokine. 2017 Apr;92:83-92. (PMID: 28119177)
J Immunol. 2007 Feb 1;178(3):1243-9. (PMID: 17237368)
Alcohol Clin Exp Res. 2000 Mar;24(3):291-9. (PMID: 10776665)
Gastroenterology. 2008 Jan;134(1):248-58. (PMID: 18166357)
Clin Exp Gastroenterol. 2021 Jun 09;14:259-267. (PMID: 34135614)
Alcohol. 2000 May;21(1):87-95. (PMID: 10946161)
Front Immunol. 2016 Jun 27;7:236. (PMID: 27446071)
Blood. 2017 Apr 6;129(14):1991-2001. (PMID: 28143882)
Nat Immunol. 2020 Sep;21(9):1119-1133. (PMID: 32719519)
J Immunol. 2005 Jan 1;174(1):456-63. (PMID: 15611271)
Hepatology. 2021 Jul;74(1):503-512. (PMID: 33314193)
J Leukoc Biol. 2006 May;79(5):941-53. (PMID: 16478920)
Clin Transl Med. 2012 Apr 27;1(1):4. (PMID: 23369364)
Med Sci Monit. 2019 Jun 15;25:4450-4456. (PMID: 31201735)
J Thromb Haemost. 2019 Oct;17(10):1683-1693. (PMID: 31211901)
Biomed Res Int. 2015;2015:903720. (PMID: 25821827)
Shock. 2013 Jan;39(1):113-4. (PMID: 23247128)
J Hepatol. 2017 Nov;67(5):1031-1050. (PMID: 28647569)
Lung. 2020 Aug;198(4):687-693. (PMID: 32462370)
Alcohol Clin Exp Res. 2006 Jan;30(1):76-85. (PMID: 16433734)
Am J Pathol. 2017 Sep;187(9):1998-2007. (PMID: 28708971)
Alcohol Clin Exp Res. 2020 Jun;44(6):1300-1311. (PMID: 32282939)
Turk Thorac J. 2016 Jan;17(1):7-14. (PMID: 29404115)
J Leukoc Biol. 2007 Oct;82(4):906-14. (PMID: 17626148)
Biochem Biophys Res Commun. 2005 Jun 24;332(1):37-42. (PMID: 15896296)
Gastroenterology. 2007 Feb;132(2):698-708. (PMID: 17258730)
Nat Commun. 2022 Nov 12;13(1):6876. (PMID: 36371424)
J Immunol. 2004 Jul 1;173(1):42-9. (PMID: 15210757)
J Biomed Biotechnol. 2011;2011:986491. (PMID: 21629707)
J Immunol Res. 2015;2015:532717. (PMID: 26114123)
J Immunol. 2016 Aug 15;197(4):1322-34. (PMID: 27421477)
Alcohol Clin Exp Res. 2021 Feb;45(2):338-350. (PMID: 33368409)
Cell. 2016 May 5;165(4):792-800. (PMID: 27153493)
Front Immunol. 2016 Aug 12;7:302. (PMID: 27570525)
Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):929-39. (PMID: 19144278)
Shock. 2004 Aug;22(2):137-44. (PMID: 15257086)
Med Mycol. 2021 Jul 14;59(8):773-783. (PMID: 33550419)
Int Rev Cell Mol Biol. 2019;348:69-121. (PMID: 31810556)
PLoS One. 2012;7(12):e50446. (PMID: 23236375)
Curr Opin Immunol. 2003 Aug;15(4):396-401. (PMID: 12900270)
Crit Care. 2006;10(6):R155. (PMID: 17092345)
Crit Care. 2011 Jul 28;15(4):R183. (PMID: 21798063)
معلومات مُعتمدة: R01 AA028763 United States AA NIAAA NIH HHS; R01 HL155064 United States HL NHLBI NIH HHS; R01AA028763 United States NH NIH HHS
فهرسة مساهمة: Keywords: alcohol use disorder; ethanol exposure; innate immune cells; sepsis; septic shock
المشرفين على المادة: 3K9958V90M (Ethanol)
تواريخ الأحداث: Date Created: 20231209 Date Completed: 20240529 Latest Revision: 20240531
رمز التحديث: 20240601
مُعرف محوري في PubMed: PMC11136611
DOI: 10.1093/jleuko/qiad156
PMID: 38066660
قاعدة البيانات: MEDLINE
الوصف
تدمد:1938-3673
DOI:10.1093/jleuko/qiad156